✦ LIBER ✦

Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: a large observational study

✍ Scribed by R. Pencek; T. Roddy; Y. Peters; M. B. De Young; K. Herrmann; L. Meller; H. Nguyen; S. Chen; K. Lutz

Book ID: 109044958
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 467 KB
Volume: 12
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2010.01201.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of sitagliptin when

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

✍ T. Vilsbøll; J. Rosenstock; H. Yki-Järvinen; W. T. Cefalu; Y. Chen; E. Luo; B. M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 574 KB

Pramlintide reduces postprandial glucose

Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study

✍ David G. Maggs; Mark Fineman; Jonathan Kornstein; Terrie Burrell; Sherwyn Schwar 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

The effect of pramlintide on hormonal, m

The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes

✍ S. A. Amiel; S. R. Heller; I. A. Macdonald; S. L. Schwartz; L. J. Klaff; J. A. R 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Efficacy and safety of sitagliptin when

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes

✍ R. Scott; T. Loeys; M. J. Davies; S. S. Engel; for the Sitagliptin Study 801 Gro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Alogliptin added to insulin therapy in p

Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia

✍ J. Rosenstock; M. S. Rendell; J. L. Gross; P. R. Fleck; C. A. Wilson; Q. Mekki 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB

Insulin glargine benefits patients with

Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients

✍ S. A. Schreiber; T. Haak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB